Clinical Trial Schedule
| Visit | Visit 1 (screening) (–21~0 day) |
Visit 2 (0 day) |
Visit 3 (42±7 day) |
Visit 4 (84±7 day) |
|---|---|---|---|---|
| Informed consent | ○ | |||
| Incousion/exclusion criteria | ○ | ○ | ||
| Demographic information | ○ | |||
| Past history investigation | ○ | |||
| Physical examination | ○ | ○ | ○ | ○ |
| Vital signs | ○ | ○ | ○ | ○ |
| Clinical laboratory examination | ○ | ○ | ○ | |
| Experimental/control capsule provision | ○ | ○ | ||
| Outcome measures | ○ | ○ | ○ | |
| Questionnaires | ○ | ○ | ||
| Adverse events | ○ | ○ | ||
| Co-administraion drug investigation | ○ | ○ | ○ | |
| Medication compliance assessment | ○ | ○ |
